Skip to main content
. 2022 Oct 11;50(8):1110–1124. doi: 10.1002/jcu.23265

FIGURE 9.

FIGURE 9

Therapeutic management of CRS‐4. ACE‐I, angiotensin‐converting enzyme inhibitor; ARBs, angiotensin receptor blockers; BB, beta blockers; CKD, chronic kidney disease; MRA, antimineralocorticoid; NSAIDs, non‐steroidal anti‐inflammatory drugs; RAAS, renin–angiotensin–aldosterone system; RRT, renal replacement therapy